Valencia Quintero, J.S. and Castillo, D. 2023. Venglustat, Lanreotide Acetate, and Tolvaptan as therapeutic options for the treatment of autosomic dominant polychistic kidney disease: a narrative review. Interdisciplinary Journal of Epidemiology and Public Health. 3, 2 (Jul. 2023), e-7246. DOI:https://doi.org/10.18041/2665-427X/ijeph.2.7246.